Pear Therapeutics (PEARQ) S-4 Registration of securities issued in business combination transactions

Exhibit 23.2

CONSENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-4 of our report dated July 16, 2021, relating to the financial statements of Pear Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

July 16, 2021